Study of Combined Effect of Bacteriophage vB3530 and Chlorhexidine on the Inactivation of Pseudomonas aeruginosa

Background Chlorhexidine (CHG) is a disinfectant commonly used in hospitals.

However, it has been reported that the excessive use of CHG can cause resistance in bacteria to this agent and even to other clinical antibiotics.

Therefore, new methods are needed to alleviate the development of CHG tolerance and reduce its dosage.

This study aimed to explore the synergistic effects of CHG in combination with bacteriophage against CHG-tolerant Pseudomonas aeruginosa ( P. aeruginosa ) and provide ideas for optimizing disinfection strategies in clinical environments as well as for the efficient use of disinfectants.

Methods The CHG-tolerant P. aeruginosa strains were isolated from the First Affiliated Hospital of Wenzhou Medical University in China.

The bacteriophage vB3530 was isolated from the sewage inlet of the hospital, and its genome was sequenced.

Time-killing curve was used to determine the antibacterial effects of vB3530 and chlorohexidine gluconate (CHG).

The phage sensitivity to 16 CHG-tolerant P. aeruginosa strains and PAO1 strain was detected using plaque assay.

The emergence rate of resistant bacterial strains was detected to determine the development of phage-resistant and CHG-tolerant strains.

Finally, the disinfection effects of the disinfectant and phage combination on the surface of the medical devices were preliminarily evaluated.

Results The results showed that (1) CHG combined with bacteriophage vB3530 significantly inhibited the growth of CHG-resistant P. aeruginosa and reduced the bacterial colony forming units (CFUs) after 24 h. (2) The combination of CHG and bacteriophage inhibited the emergence of phage-resistant and CHG-tolerant strains.

(3) The combination of CHG and bacteriophage significantly reduced the bacterial load on the surface of medical devices.

Conclusions In this study, the combination of bacteriophage vB3530 and CHG presented a combined inactivation effect to CHG-tolerant P. aeruginosa and reduced the emergence of strains resistant to CHG and phage.

This study demonstrated the potential of bacteriophage as adjuvants to traditional disinfectants.

The use of bacteriophage in combination with commercial disinfectants might be a promising method for controlling the spread of bacteria in hospitals.